IDBE - ID Biomedical Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDBE - ID Biomedical

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: streetlead who wrote (7)	8/10/1999 6:17:00 PM
From: Kaiser Soza	Read Replies (1) of 25

I agree with you, however the company is in need of "CASH" even though the science side is exceptional. I noted that Steve feels the same but is concerned with dilution. I think the dilution is a non-event given the size of markets IDBE is going after. Another company, Inex Pharmaceuticals, recently had low cash and raised $12 million at $2 (Canadian) when the stock was $2.40. The shares hit $5 within a week. Most analysts today will not recommend a company with less that 2 years of cash. IDBE's burn rate is reasonable and with a cash injection the shares should respond well and the company may once again get on the radar screen of analysts. The ability of this company to generate earnings within the next year will make it rather unique as they continue to elephant hunt in other markets such as vaccine and further applications for tests. I share your very bullish views on the company, but can be accused of wishful thinking due to my overweight position in this one. Lets hope they deliver!!!Regards, Kaiser...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next